Medtronic plc, a prominent healthcare technology company, has announced its participation in the upcoming 26th annual Barclays global healthcare conference. The event is scheduled for Tuesday, March 12, 2024. Karen Parkhill, Medtronic’s executive vice president and chief financial officer, will be available to address inquiries regarding the company starting at 8:00 a.m. EDT (7:00 a.m. CDT).
For those interested, a live webcast of the Q&A session will be accessible on March 12, 2024, through the Events section of the Medtronic investor relations website. Additionally, an archived version of the Q&A session will be made available on the same webpage later in the day.
About Medtronic
Medtronic plc, headquartered in Dublin, Ireland, stands as a leading global healthcare technology company committed to tackling the most challenging health problems humanity faces. Their mission, “to alleviate pain, restore health, and extend life,” guides a diverse team of over 90,000 individuals across 150 countries. Medtronic’s portfolio includes technologies and therapies addressing 70 health conditions, spanning cardiac devices, surgical robotics, insulin pumps, patient monitoring systems, and more.
Driven by a blend of knowledge, curiosity, and a desire to make a difference, Medtronic strives to deliver innovative solutions that transform lives on a vast scale. With a commitment to insight-driven care, customer-centric experiences, and improved outcomes, Medtronic aims to engineer the extraordinary in all their endeavors.
